Pasquet A, Robert A, D'Hondt A M, Dion R, Melin J A, Vanoverschelde J L
Divisions of Cardiology and Nuclear Medicine, University of Louvain Medical School, Brussels, Belgium.
Circulation. 1999 Jul 13;100(2):141-8. doi: 10.1161/01.cir.100.2.141.
Previous studies showed that thallium scintigraphy and dobutamine echocardiography were accurate, noninvasive ways of predicting contractile recovery after revascularization in patients with left ventricular (LV) dysfunction. However, the prognostic impact of such methods remains uncertain.
We prospectively studied 137 consecutive patients with coronary disease and LV dysfunction who underwent exercise-redistribution-reinjection thallium scintigraphy and dobutamine echocardiography to identify myocardial ischemia and viability. A total of 94 patients subsequently underwent revascularization, and 43 underwent medical treatment. The primary endpoint was cardiac mortality, and mean follow-up was 33+/-10 months. Twenty-four patients died of cardiac causes. By Cox's regression analysis, long-term survival was related to the extent of coronary disease, the presence of diabetes, type of treatment, the presence of ischemic myocardium as determined by thallium scintigraphy, and the presence of viable myocardium as determined by both tests. Three-year survival was greater in patients with ischemic myocardium (as determined by thallium scintigraphy) or viable myocardium (as determined by both tests) who underwent revascularization than in the other groups (P=0.018 with thallium; P<0.001 with dobutamine). Subgroup analyses indicated that among patients with 1- or 2-vessel disease, only those with ischemic or viable myocardium improved survival after revascularization, whereas in patients with 3-vessel or left main diseases, revascularization always improved survival, albeit more in the presence of ischemic or viable myocardium.
Among the parameters commonly available in patients with LV ischemic dysfunction, the presence of ischemic myocardium (as determined by thallium scintigraphy) and that of viable myocardium (as determined by dobutamine echocardiography) are independent predictors of subsequent mortality. These observations may be useful in the preoperative selection of patients for revascularization.
先前的研究表明,铊闪烁扫描和多巴酚丁胺超声心动图是预测左心室(LV)功能障碍患者血管重建术后收缩功能恢复的准确、非侵入性方法。然而,这些方法的预后影响仍不确定。
我们前瞻性地研究了137例连续的冠心病和LV功能障碍患者,他们接受了运动-再分布-再注射铊闪烁扫描和多巴酚丁胺超声心动图检查以识别心肌缺血和存活心肌。随后,94例患者接受了血管重建,43例接受了药物治疗。主要终点是心脏死亡率,平均随访时间为33±10个月。24例患者死于心脏原因。通过Cox回归分析,长期生存与冠心病的程度、糖尿病的存在、治疗类型、铊闪烁扫描确定的缺血心肌的存在以及两项检查确定的存活心肌的存在有关。接受血管重建的缺血心肌(由铊闪烁扫描确定)或存活心肌(由两项检查确定)患者的三年生存率高于其他组(铊闪烁扫描P = 0.018;多巴酚丁胺P<0.001)。亚组分析表明,在单支或双支血管疾病患者中,只有那些有缺血或存活心肌的患者在血管重建后生存率提高,而在三支血管或左主干疾病患者中,血管重建总是能提高生存率,尽管在有缺血或存活心肌的情况下提高得更多。
在LV缺血功能障碍患者中常见的参数中,缺血心肌(由铊闪烁扫描确定)和存活心肌(由多巴酚丁胺超声心动图确定)的存在是后续死亡率的独立预测因素。这些观察结果可能有助于血管重建术前患者的选择。